Owing to these facts, Caruana and coworkers induced heparanase (HPSE) expression in CAR-modified T cells, which improved the ECM degradation capacity and the anti-tumor activity of co-expressed CAR T cells (i.e., expressed CAR and HPSE) in solid tumors [32]. The gene discussed is HPSE; the disease is neoplasm.